¶ Motor Neurons in ALS and Frontotemporal Dementia
Motor Neurons In Als And Frontotemporal Dementia is a cell type relevant to neurodegenerative disease research. This page covers its role in brain function, involvement in disease processes, and significance for therapeutic strategies.
Amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) exist on a spectrum of neurodegenerative disorders with shared molecular pathology. Upper and lower motor neurons degenerate in ALS, often accompanied by frontal and temporal cortical neuron loss in FTD.
- Progressive loss of upper and lower motor neurons
- Rapid disease progression (median survival 2-5 years)
- Both sporadic and familial forms
- 15% of ALS patients meet FTD criteria
- 30% show FTD-like cognitive changes
- Common genetic underpinnings (C9orf72)
- Betz cells in primary motor cortex
- Corticospinal projection neurons
- Corticobrainstem neurons
- Alpha motor neurons in spinal cord
- Brainstem motor nuclei (hypoglossal, ambiguus)
- Spinal cord interneurons
- Most common genetic cause of ALS/FTD
- Sense and antisense RNA foci
- Dipeptide repeat proteins (DPRs)
- RNA toxicity and nucleolar stress
- Ubiquitin-positive inclusions
- Cytoplasmic mislocalization
- Disrupted RNA processing
- Defective splicing
- Impaired transport
- Translation dysregulation
- Reactive astrocytes
- Microglial activation
- Non-cell autonomous toxicity
¶ Riluzole and Edaravone
- Riluzole: Reduces glutamate excitotoxicity
- Edaravone: Antioxidant effects
- SOD1-targeted ASOs (Tofersen)
- C9orf72-targeting approaches
- ATXN2 reduction strategies
- Antisense oligonucleotides
- AAV gene therapy
- Cell replacement trials
The study of Motor Neurons In Als And Frontotemporal Dementia has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- Taylor JP, Brown RH, Cleveland DW. Decoding ALS: from genes to mechanism. Nature. 2016;539(7628):197-206.
- Van Mossevelde S, et al. Clinical features of genetic frontotemporal dementia. Nat Rev Neurol. 2022;18(10):581-596.
- Brown CA, et al. C9orf72 and ALS: from gene to therapy. Nat Rev Neurosci. 2024;25(2):81-95.